Endocrine Abstracts

Introduction: Morgagni–Stewart–Morel syndrome is defined as the absolute presence of hyperostosis frontalis interna, associated with metabolic, endocrine, and neuropsychiatric disorders. There are very few cases reported in the literature and some experts do not even recognize it but the exact etiology of the syndrome remains unclear; some theories relate to estrogen dysfunction, obesity and leptin dysfunction, and genetic alterations....

Introduction: Primary hyperparathyroidism is a condition in which one or more parathyroid glands have a pathological secretion of parathyroid hormone due to their abnormal function. Secondary hyperparathyroidism has normal parathyroid glands, but an abnormal secretion of PTH because of an underlying condition that influence their activity. It is important to differentiate between primary and secondary hyperparathyroidism because of the different treatment.<p class="abstext...

A 39 years old pacient presented for the first time in may 2023 with altered vision, dizziness, tachycardia and palpitations with paraclinical investigations suggestive for inappropiate TSH secretion: TSH=5.31 μUI/ml (NR: 0.27-0.42), fT4=56.8 pmol/l (NR: 11.9-21.6), fT3=17.4 ng/dl (NR: 3.1-6.8), ATPO <9 UI/ml, ATG=12.7 UI/ml (NR: 0-115). He has been treated with antithyroid drugs (Thiamazole 10 mg per day). The thyroid ultrasound and ophthalmological exam were normal....

Introduction: Adrenal hyperplasia is found in more than 15% of abdominal imaging procedures in adults, unrelated to endocrine disorders, especially after the COVID era. Adrenal management is consequently recommended.Aim: To retrospectively evaluate the adrenal status in terms of morphological progression and functional impairment of adrenal function, in a cohort of cases admitted at least yearly in the National Institute of Endocrinology, Bucharest, Roma...

Introduction: Assessment of adrenal insufficiency (AI) is done routinely through Synacthen test. However, the conventional high dose (250 μg) stimulation is supra-physiological, therefore 1 μg low dose test was developed.Aim: to investigate the utility of the Low-dose test vs the High-dose test, in patients with suspected central AI, in a tertiary centre of endocrinology, in the National Institute of Endocrinology, Bucharest, Romania.<p cla...

Introduction: Pheochromocytoma is a rare tumor, representing a cause of secondary endocrine hypertension. Traditionally, prior to the widespread availability of imaging investigations, pheochromocytoma was diagnosed based on the triad: headache, palpitations and sweating. Diagnosis is crucial, as 40-50% of pheochromocytoma patients exhibit genetic mutations associated with multiple syndromes, such as MEN2 syndrome, succinate dehydrogenase enzyme mutations, neurofibromatosis ty...